Deutsch English Français

Contact

EP2854852

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2854852

EP2854852 - COMPOSITIONS AND METHODS FOR TREATING CROHN'S DISEASE AND RELATED CONDITIONS AND INFECTIONS [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 02.10.2020 Database last updated on 09.09.2024
Former	Examination is in progress Status updated on 27.04.2018
Most recent event Tooltip	02.10.2020	Application deemed to be withdrawn	published on 04.11.2020 [2020/45]
Applicant(s)	For all designated states Agrawal, Gaurav Unit 1 2 Malvern Ave. Manly, NSW 2095 / AU
	[2018/49]
Former [2016/38]	For all designated states Centre for Digestive Diseases Level 1 229 Great North Road Five Dock, NSW 2046 / AU
Former [2016/29]	For all designated states CENTRE FOR DIGESTIVE DISEASES PTY LTD Level 1 229 Great North Road Five Dock, NSW 2046 / AU
Former [2015/15]	For all designated states Agrawal, Gaurav Unit 1, 2 Malvern Avenue Manly, New South Wales 2095 / AU
Inventor(s)	01 / AGRAWAL Gaurav 3/14 Cove Avenue Manly, New South Wales 2095 / AU
	[2016/38]
Former [2015/15]	01 / see applicant ...
Representative(s)	J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB
	[N/P]
Former [2015/15]	Roques, Sarah Elizabeth J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB
Application number, filing date	13801095.4	04.06.2013
	WO2013AU00587
Priority number, date	AU20120902307	04.06.2012 Original published format: AU 2012902307
	[2015/15]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2013181694
	Date:	12.12.2013
	Language:	EN
	[2013/50]
	Type:	A1 Application with search report
	No.:	EP2854852
	Date:	08.04.2015
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 12.12.2013 takes the place of the publication of the European patent application.
	[2015/15]
Search report(s)	International search report - published on:	AU	12.12.2013
	(Supplementary) European search report - dispatched on:	EP	16.03.2016
Classification	IPC:	A61K39/395, A61P31/04, A61P1/00, A23C9/123, A23G4/06, A23G9/32, A23G3/36, A61K39/40, A61K31/133, A61K31/4164, A61K31/435, A61K31/496, A61K31/498, A61K31/00	[2016/15]
	CPC:	A61K31/133 (EP,US); A61K39/395 (IL); A61K39/39533 (US); A23C9/123 (US); A23G3/36 (US); A23G4/06 (US); (+) A23G9/32 (US); A61K31/4164 (EP,US); A61K31/435 (EP,US); A61K31/496 (EP,US); A61K31/498 (EP,IL,US); A61K31/7048 (EP,IL,US); A61K33/00 (EP,US); A61K39/3955 (EP,US); A61K39/40 (EP,IL,US); A61P1/00 (EP); A61P1/04 (EP); A61P29/00 (EP); A61P31/04 (EP); A61P37/06 (EP); A61P43/00 (EP); A61K2039/505 (US); Y02A50/30 (EP,US) (-)
	C-Set:	A61K39/3955, A61K39/00 (US,IL,EP); A61K39/40, A61K39/00 (IL,EP,US)
	Former IPC [2015/15]	A61K39/395, A61P31/04, A61P1/00
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/15]
Title	German:	ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON MORBUS CROHN UND VERWANDTEN ERKRANKUNGEN UND INFEKTIONEN	[2015/15]
	English:	COMPOSITIONS AND METHODS FOR TREATING CROHN'S DISEASE AND RELATED CONDITIONS AND INFECTIONS	[2015/15]
	French:	COMPOSITIONS ET PROCÉDÉS DE TRAITEMENT DE LA MALADIE DE CROHN ET DES PATHOLOGIES ET INFECTIONS ASSOCIÉES	[2015/15]
Entry into regional phase	18.12.2014	National basic fee paid
	18.12.2014	Search fee paid
	18.12.2014	Designation fee(s) paid
	18.12.2014	Examination fee paid
Examination procedure	18.12.2014	Examination requested [2015/15]
	10.10.2016	Amendment by applicant (claims and/or description)
	03.05.2018	Despatch of a communication from the examining division (Time limit: M06)
	09.11.2018	Reply to a communication from the examining division
	13.03.2019	Invitation to indicate the basis for amendments (Time limit: M01)
	01.04.2019	Reply to an invitation to indicate the basis for amendments
	30.04.2019	Despatch of a communication from the examining division (Time limit: M06)
	08.11.2019	Reply to a communication from the examining division
	21.11.2019	Despatch of a communication from the examining division (Time limit: M06)
	03.06.2020	Application deemed to be withdrawn, date of legal effect [2020/45]
	25.06.2020	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2020/45]
Divisional application(s)	EP20152020.2 / EP3659598
	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 03.05.2018
Fees paid	Renewal fee
	29.06.2015	Renewal fee patent year 03
	14.12.2016	Renewal fee patent year 04
	16.06.2017	Renewal fee patent year 05
	12.06.2018	Renewal fee patent year 06
	13.06.2019	Renewal fee patent year 07
	31.03.2020	Renewal fee patent year 08
	Penalty fee
	Additional fee for renewal fee
	30.06.2016	04 M06 Fee paid on 14.12.2016
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[IY] - JOHN HERMON-TAYLOR, "Mycobacterium avium subspecies paratuberculosis, Crohn's disease and the Doomsday scenario", GUT PATHOGENS, London, UK, (20090101), vol. 1, no. 1, doi:10.1186/1757-4749-1-15, ISSN 1757-4749, page 15, XP055221937 [I] 1-12 * page 4, column r, paragraph 22 - paragraph 3 * [Y] 1-12 DOI: http://dx.doi.org/10.1186/1757-4749-1-15
		[XY] - R. L. WEST ET AL, "Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study", ALIMENTARY PHARMACOLOGY & THERAPEUTICS., GB, (20041201), vol. 20, no. 11-12, doi:10.1111/j.1365-2036.2004.02247.x, ISSN 0269-2813, pages 1329 - 1336, XP055222095 [X] 1,3,4,6,7,11,12 * page 1334, column l * * table 1 * [Y] 1-12 DOI: http://dx.doi.org/10.1111/j.1365-2036.2004.02247.x
		[XY] - KATSANOS K H ET AL, "Fournier's gangrene complicating ulcerative pancolitis", JOURNAL OF CROHN'S AND COLITIS, ELSEVIER BV, NL, vol. 4, no. 2, ISSN 1873-9946, (20100601), pages 203 - 206, (20100512), XP027047690 [X] 1,3,4,7,11,12 * page 205, column r, paragraph 1 * [Y] 1-12
	International search	[X]WO2007120720 (ABBOTT BIOTECH LTD, et al);
		[X] - JIANG, T. ET AL., "Fournier gangrene associated with Crohn disease", MAYO CLIN PROC., (2000), vol. 75, no. 6, pages 647 - 649, XP055178933 DOI: http://dx.doi.org/10.4065/75.6.647
		[A] - LAVY, A. ET AL., "Hyperbaric oxygen for perianal Crohn's disease", J CLIN GASTROENTEROL., (1994), vol. 19, no. 3, pages 202 - 205, XP008175670 DOI: http://dx.doi.org/10.1097/00004836-199410000-00006
		[A] - ROSSIGNOL, D. A., "Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis", MEDICAL GAS RESEARCH, (2012), vol. 2, no. 1, page 6, XP021124451 DOI: http://dx.doi.org/10.1186/2045-9912-2-6
		[X] - NELSON, E. W. JR. ET AL., "Closure of refractory perineal Crohn's lesion. Integration of hyperbaric oxygen into case management", DIG DIS SCI., (1990), vol. 35, no. 12, pages 1561 - 1565, XP008175676 DOI: http://dx.doi.org/10.1007/BF01540577

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p